Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer
Keyword(s):
2004 ◽
Vol 16
(sup4)
◽
pp. 104-107
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1997 ◽
Vol 27
(3)
◽
pp. 166-169
◽
Keyword(s):
Keyword(s):
Keyword(s):